TY - JOUR
T1 - Segregation of NF-κB activation through NEMO/IKKγ by Tax and TNFα
T2 - Implications for stimulus-specific interruption of oncogenic signaling
AU - Iha, Hidekatsu
AU - Kibler, Karen V.
AU - Yedavalli, Venkat R.K.
AU - Peloponese, Jean Marie
AU - Haller, Kerstin
AU - Miyazato, Akiko
AU - Kasai, Takefumi
AU - Jeang, Kuan Teh
PY - 2003/12/4
Y1 - 2003/12/4
N2 - Nuclear factor-κB essential modulator (NEMO), also called IKKγ, has been proposed as a 'universal' adaptor of the I-κB kinase (IKK) complex for stimuli such as proinflammatory cytokines, microbes, and the HTLV-I Tax oncoprotein. Currently, it remains unclear whether the many signals that activate NF-κB through NEMO converge identically or differently. We have adopted two approaches to answer this question. First, we generated and targeted intracellularly three NEMO-specific monoclonal antibodies (mAbs). These mAbs produced two distinct intracellular NF-κB inhibition profiles segregating TNFα from Tax activation. Second, using NEMO knockout mouse fibroblasts and 10 NEMO mutants, we found that different regions function in trans either to complement or to inhibit dominantly TNFα, IL-1β, or Tax activation of NF-κB. For instance, NEMO (1-245 amino acids) supported Tax-mediated NF-κB activation, but did not serve TNFα- or IL-1β signaling. Altogether, our findings indicate that while NEMO 'universally' adapts numerous NF-κB activators, it may do so through separable domains. We provide the first evidence that selective targeting of NEMO can abrogate oncogenic Tax signaling without affecting signals used for normal cellular metabolism.
AB - Nuclear factor-κB essential modulator (NEMO), also called IKKγ, has been proposed as a 'universal' adaptor of the I-κB kinase (IKK) complex for stimuli such as proinflammatory cytokines, microbes, and the HTLV-I Tax oncoprotein. Currently, it remains unclear whether the many signals that activate NF-κB through NEMO converge identically or differently. We have adopted two approaches to answer this question. First, we generated and targeted intracellularly three NEMO-specific monoclonal antibodies (mAbs). These mAbs produced two distinct intracellular NF-κB inhibition profiles segregating TNFα from Tax activation. Second, using NEMO knockout mouse fibroblasts and 10 NEMO mutants, we found that different regions function in trans either to complement or to inhibit dominantly TNFα, IL-1β, or Tax activation of NF-κB. For instance, NEMO (1-245 amino acids) supported Tax-mediated NF-κB activation, but did not serve TNFα- or IL-1β signaling. Altogether, our findings indicate that while NEMO 'universally' adapts numerous NF-κB activators, it may do so through separable domains. We provide the first evidence that selective targeting of NEMO can abrogate oncogenic Tax signaling without affecting signals used for normal cellular metabolism.
KW - Adult T-cell leukemia
KW - HTLV-I
KW - NEMO/IKKγ
KW - NF-κB
KW - Oncogenic transformation
KW - TNFα
KW - Tax
UR - http://www.scopus.com/inward/record.url?scp=0347363826&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0347363826&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1207058
DO - 10.1038/sj.onc.1207058
M3 - Article
C2 - 14654787
AN - SCOPUS:0347363826
SN - 0950-9232
VL - 22
SP - 8912
EP - 8923
JO - Oncogene
JF - Oncogene
IS - 55
ER -